{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:45:22Z","timestamp":1760204722242},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T00:00:00Z","timestamp":1422057600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00520-015-2621-0","type":"journal-article","created":{"date-parts":[[2015,1,23]],"date-time":"2015-01-23T14:40:42Z","timestamp":1422024042000},"page":"1321-1329","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of antibiotic prophylaxis with cotrimoxazole\/colistin (COT\/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia"],"prefix":"10.1007","volume":"23","author":[{"given":"Karin","family":"Mayer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Hahn-Ast","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"M\u00fcckter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Krause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Felder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Bekeredjian-Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Molitor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Brossart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"von Lilienfeld-Toal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,24]]},"reference":[{"key":"2621_CR1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJMoa050078","volume":"353","author":"M Cullen","year":"2005","unstructured":"Cullen M, Steven N, Billingham L, Gaunt C, Hastings M, Simmonds P, Stuart N, Rea D, Bower M, Fernando I, Huddart R, Gollins S, Stanley A (2005) Simple investigation in neutropenic individuals of the frequency of infection after chemotherapy +\/- antibiotic in a number of tumours (SIGNIFICANT) Trial Group. Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. N Engl J Med 353:988\u2013998","journal-title":"N Engl J Med"},{"key":"2621_CR2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","volume":"353","author":"G Bucaneve","year":"2005","unstructured":"Bucaneve G, Micozzi A, Menichetti F, Martino P, Dionisi MS, Martinelli G, Allione B, D'Antonio D, Buelli M, Nosari AM, Cilloni D, Zuffa E, Cantaffa R, Specchia G, Amadori S, Fabbiano F, Deliliers GL, Lauria F, Fo\u00e0 R, for the Gruppo Italiano Malattie Ematologiche dell\u2019Adulto (GIMEMA) Infection Program (2005) Levoflocaxin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977\u2013987","journal-title":"N Engl J Med"},{"key":"2621_CR3","volume":"1","author":"A Gafter-Gvili","year":"2012","unstructured":"Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie TA, van de Wetering MD, Kremer LCM, Leibovici L (2012) Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy. Cochrane Database Syst Rev 1, CD004386. doi: 10.1002\/14651858.CD004386.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"2621_CR4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1200\/JCO.2012.45.8661","volume":"31","author":"CR Flowers","year":"2013","unstructured":"Flowers CR, Seidenfeld J, Bow EJ, Karten C, Gleason C, Hawley DK, Kuderer NM, Langston AA, Marr KA, Rolston KV, Ramsey SD (2013) Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 31:794\u2013810","journal-title":"J Clin Oncol"},{"key":"2621_CR5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M, Infectious Diseases Working Party (AGIHO); German Society of Hematology and Oncology (DGHO) (2013) Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors. Ann Hematol 92:433\u2013442","journal-title":"Ann Hematol"},{"key":"2621_CR6","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1038\/sj.leu.2403528","volume":"18","author":"RF Schlenk","year":"2004","unstructured":"Schlenk RF, Fr\u00f6hling S, Hartmann F, Fischer JT, Glasmacher A, del Valle F, Grimminger W, G\u00f6tze K, Waterhouse C, Schoch R, Pralle H, Mergenthaler HG, Hensel M, Koller E, Kirchen H, Preiss J, Salwender H, Biedermann HG, Kremers S, Griesinger F, Benner A, Addamo B, D\u00f6hner K, Haas R, D\u00f6hner H, AML Study Group Ulm (2004) Phase III study of all-trans retinoic acid in previously untreated patients 61\u00a0years or older with acute myeloid leukemia. Leukemia 18:1798\u20131803","journal-title":"Leukemia"},{"key":"2621_CR7","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.3324\/haematol.11516","volume":"92","author":"M Lilienfeld-Toal von","year":"2007","unstructured":"von Lilienfeld-Toal M, Hahn-Ast C, Kirchner H, Flieger D, D\u00f6lken G (2007) A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy. Haematologica 92:1719\u20131720","journal-title":"Haematologica"},{"key":"2621_CR8","unstructured":"Clinical and Laboratory Standards Institute (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. ISBN 1-56238-625-5"},{"key":"2621_CR9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jac\/26.suppl_D.137","volume":"26","author":"M Arning","year":"1990","unstructured":"Arning M, Wolf HH, Aul C, Heyll A, Scharf RE, Scheider W (1990) Infection prophylaxis in neutropenic patients with acute leukemia-a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole\/colistin. J Antimicrob Chemother 26:137\u2013142","journal-title":"J Antimicrob Chemother"},{"key":"2621_CR10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0959-8049(92)90138-R","volume":"28","author":"JP Donelly","year":"1992","unstructured":"Donelly JP, Maschmeyer G, Daenen S (1992) Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group. Eur J Cancer 28:873\u2013878","journal-title":"Eur J Cancer"},{"key":"2621_CR11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","volume":"16","author":"EA Engels","year":"1998","unstructured":"Engels EA, Lau J, Barza M (1998) Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. J Clin Oncol 16:1179\u20131187","journal-title":"J Clin Oncol"},{"issue":"Suppl D","key":"2621_CR12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/jac\/41.suppl_4.7","volume":"41","author":"BA Oppenheim","year":"1998","unstructured":"Oppenheim BA (1998) The changing pattern of infection in neutropenic patients. J Antimicrob Chemother 41(Suppl D):7\u201311","journal-title":"J Antimicrob Chemother"},{"key":"2621_CR13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1086\/374339","volume":"36","author":"H Wisplinghoff","year":"2003","unstructured":"Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB (2003) Current trends in the epidemiology of nosocomial bloodstream infections in patients with haematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 36:1103\u20131110","journal-title":"Clin Infect Dis"},{"key":"2621_CR14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1086\/422647","volume":"39","author":"RE Polk","year":"2004","unstructured":"Polk RE, Jaohnson CK, McClish D, Wenzel RP, Edmond MB (2004) Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities. Clin Infect Dis 39:497\u2013503","journal-title":"Clin Infect Dis"},{"key":"2621_CR15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/jac\/dkm514","volume":"61","author":"C Cattaneo","year":"2008","unstructured":"Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G (2008) Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution. J Antimicrob Chemother 61:721\u2013728","journal-title":"J Antimicrob Chemother"},{"key":"2621_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1159\/000329661","volume":"57","author":"Y Bhusal","year":"2011","unstructured":"Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV (2011) Incidence of fluoroquinolone-resistant and extended-spectrum \u00df-lactamase-producing Escherichia coli at a comprehensive cancer center in the United States. Chemotherapy 57:335\u2013338","journal-title":"Chemotherapy"},{"key":"2621_CR17","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Saheb N, Coulombe MA, Alary ME, Corriveau MP, Authier S, Leblanc M, Rivard G, Bettez M, Primeau V, Nguyen M, Jacob CE, Lanthier L (2005) Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41:1254\u20131260","journal-title":"Clin Infect Dis"},{"key":"2621_CR18","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jac\/dkf009","volume":"49","author":"EM Graffunder","year":"2002","unstructured":"Graffunder EM, Venezia RA (2002) Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 49:999\u20131005","journal-title":"J Antimicrob Chemother"},{"key":"2621_CR19","first-page":"1","volume":"0","author":"KA Simondsen","year":"2012","unstructured":"Simondsen KA, Reed MP, Mably MS, Zhang Y, Longo WL (2012) Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation. J Oncol Pharm Pract 0:1\u20137","journal-title":"J Oncol Pharm Pract"},{"key":"2621_CR20","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/j.ijid.2010.12.010","volume":"15","author":"Y Chong","year":"2011","unstructured":"Chong Y, Yakushiji H, Ito Y, Kamimura T (2011) Clinical impact of fluoroquinolone prophylaxis in neutropenic patients with haematological malignancies. Int J Infect Dis 15:e277\u2013e281","journal-title":"Int J Infect Dis"},{"key":"2621_CR21","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/BF01643198","volume":"5","author":"H Heimpel","year":"1987","unstructured":"Heimpel H, Raghavachar A (1987) Hematological side effects of co-trimoxazole. Infection 5:248\u2013252","journal-title":"Infection"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2621-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2621-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2621-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T22:03:42Z","timestamp":1566252222000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2621-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,24]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2621-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,24]]}}}